Research and Development

Showing 15 posts of 9596 posts found.

MedImmune buys AlphaCore

April 9, 2013 Research and Development AlphaCore, AstraZeneca, MedImmune

AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …

New head at European Medicines Agency

April 8, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA

The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …

Star commercial academy appoints director

March 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star

Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …
GSK image

FDA delays GSK flu vaccine

March 27, 2013 Research and Development, Sales and Marketing FDA, GSK, Vaccine

The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …
biogen idec image

Multiple sclerosis rivals gain EU approval

March 27, 2013 Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS

Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …
stuart_mcguire_12a

Chiltern announces two promotions

March 26, 2013 Manufacturing and Production, Research and Development, Sales and Marketing chiltern

Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …
sanofi image

Sanofi in immunotherapy tie-up

March 26, 2013 Research and Development, Sales and Marketing Transgene, snaofi

Sanofi has signed a 15-year deal with biopharma company Transgene to produce a platform to help create a range of …

Africa rising

March 26, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt

Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …

New chief executive for Eyevensys

March 26, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys

Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …
mike_williams_leo_pharma

LEO Pharma appoints two divisional directors

March 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma

LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …

Contract research news in brief

March 22, 2013 Research and Development Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv Health

inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.

Budget 2013: pharma ‘pleased’

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK

Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
steven_burrill-headshot-cropped

Targacept makes changes to Board and management

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept

Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …
screen_shot_2013-03-20_at_09

Ziarco appoints John LaMattina as R&D advisor

March 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …

Knee trial for Merck KGaA

March 19, 2013 Research and Development, Sales and Marketing Merck KGaA, knee, nordic

Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …
The Gateway to Local Adoption Series

Latest content